These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15925250)

  • 1. Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC-MS/MS.
    Chang D; Kolis SJ; Linderholm KH; Julian TF; Nachi R; Dzerk AM; Lin PP; Lee JW; Bansal SK
    J Pharm Biomed Anal; 2005 Jul; 38(3):487-96. PubMed ID: 15925250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography-tandem mass spectrometry.
    van den Broek I; Sparidans RW; Huitema AD; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):49-58. PubMed ID: 16713406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices: measurement of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma.
    van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):245-59. PubMed ID: 17500050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of sifuvirtide, a novel anti-HIV-1 peptide, in monkeys and its inhibitory concentration in vitro.
    Dai SJ; Dou GF; Qiang XH; Song HF; Tang ZM; Liu DS; Liu XW; Yang LM; Zheng YT; Liang Q
    Acta Pharmacol Sin; 2005 Oct; 26(10):1274-80. PubMed ID: 16174446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of a novel HIV fusion inhibitor (sifuvirtide) in HIV infected human plasma using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Che J; Meng Q; Chen Z; Hou Y; Shan C; Cheng Y
    J Pharm Biomed Anal; 2010 Mar; 51(4):927-33. PubMed ID: 19931996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detection.
    Vlase L; Imre S; Muntean D; Leucuta SE
    J Pharm Biomed Anal; 2007 Jul; 44(3):652-7. PubMed ID: 16962733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
    Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of the large polypeptide glucagon by protein precipitation and LC/MS.
    Delinsky DC; Hill KT; White CA; Bartlett MG
    Biomed Chromatogr; 2004 Nov; 18(9):700-5. PubMed ID: 15386587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
    Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of Orlistat (tetrahydrolipostatin, Ro 18-0647) in human plasma by high-performance liquid chromatography coupled with ion spray tandem mass spectrometry.
    Bennett PK; Li YT; Edom R; Henion J
    J Mass Spectrom; 1997 Jul; 32(7):739-49. PubMed ID: 9241856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients.
    D'Avolio A; Sciandra M; de Requena DG; Ibañez A; Bonora S; Di Perri G
    Ther Drug Monit; 2006 Feb; 28(1):110-5. PubMed ID: 16418704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of glycyrrhizin, a marker component in radix Glycyrrhizae, and its major metabolite glycyrrhetic acid in human plasma by LC-MS/MS.
    Lin ZJ; Qiu SX; Wufuer A; Shum L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):201-7. PubMed ID: 15639440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying metabolite ions of peptide drugs in the presence of an in vivo matrix background.
    Cuyckens F; Dillen L; Cools W; Bockx M; Vereyken L; de Vries R; Mortishire-Smith RJ
    Bioanalysis; 2012 Mar; 4(5):595-604. PubMed ID: 22409556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a liquid chromatographic/mass spectrometry method for quantification of tetrandrine in rat plasma and its application to pharmacokinetic study.
    Song N; Zhang S; Li Q; Liu C
    J Pharm Biomed Anal; 2008 Nov; 48(3):974-9. PubMed ID: 18650047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A liquid chromatography-mass spectrometry assay for simultaneous determination of two antimalarial thiazolium compounds in human and rat matrices.
    Taudon N; Margout D; Calas M; Kezutyte T; Vial HJ; Bressolle FM
    J Pharm Biomed Anal; 2008 Nov; 48(3):1001-5. PubMed ID: 18678456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
    Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive method for the determination of ibutilide in human plasma by liquid chromatography-tandem mass spectrometry.
    Tian L; Li Y; Huang Y; Kuang F; Li F; Hua L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):81-5. PubMed ID: 15664337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study.
    Bhaumik U; Ghosh A; Sarkar AK; Bose A; Selvan PS; Sengupta P; Chakraborty US; Ghosh D; Pal TK
    J Pharm Biomed Anal; 2008 Dec; 48(5):1404-10. PubMed ID: 18986788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validated LC-MS-MS method for determination of m-nisoldipine polymorphs in rat plasma and its application to pharmacokinetic studies.
    Wang H; Zhang L; Wang Q; Yuan Z; Li M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):71-6. PubMed ID: 16567136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.